315 related articles for article (PubMed ID: 28886076)
1. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR; Keene KS; Tuomela JM; Forero-Torres A; Desmond R; Vuopala KS; Harris KW; Merner ND; Selander KS
PLoS One; 2017; 12(9):e0183832. PubMed ID: 28886076
[TBL] [Abstract][Full Text] [Related]
2. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
3. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
4. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
[TBL] [Abstract][Full Text] [Related]
6. Demographic, lifestyle, and genetic determinants of circulating concentrations of 25-hydroxyvitamin D and vitamin D-binding protein in African American and European American women.
Yao S; Hong CC; Bandera EV; Zhu Q; Liu S; Cheng TD; Zirpoli G; Haddad SA; Lunetta KL; Ruiz-Narvaez EA; McCann SE; Troester MA; Rosenberg L; Palmer JR; Olshan AF; Ambrosone CB
Am J Clin Nutr; 2017 Jun; 105(6):1362-1371. PubMed ID: 28424184
[No Abstract] [Full Text] [Related]
7. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
[TBL] [Abstract][Full Text] [Related]
8. A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study.
Weng LC; Cushman M; Pankow JS; Basu S; Boerwinkle E; Folsom AR; Tang W
Hum Mol Genet; 2015 Apr; 24(8):2401-8. PubMed ID: 25552651
[TBL] [Abstract][Full Text] [Related]
9. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
10. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
11. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
13. Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.
Mitchell KA; Zingone A; Toulabi L; Boeckelman J; Ryan BM
Clin Cancer Res; 2017 Dec; 23(23):7412-7425. PubMed ID: 29196495
[No Abstract] [Full Text] [Related]
14. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
[TBL] [Abstract][Full Text] [Related]
15. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.
Newman LA; Jenkins B; Chen Y; Oppong JK; Adjei E; Jibril AS; Hoda S; Cheng E; Chitale D; Bensenhaver JM; Awuah B; Bekele M; Abebe E; Kyei I; Aitpillah F; Adinku M; Nathanson SD; Jackson L; Jiagge E; Merajver S; Petersen LF; Proctor E; Gyan KK; Martini R; Kittles R; Davis MB
Ann Surg; 2019 Sep; 270(3):484-492. PubMed ID: 31356281
[TBL] [Abstract][Full Text] [Related]
16. Time will tell: Circadian clock dysregulation in triple negative breast cancer.
Rida P; Syed MI; Aneja R
Front Biosci (Schol Ed); 2019 Mar; 11(1):178-192. PubMed ID: 30844743
[TBL] [Abstract][Full Text] [Related]
17. Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).
Gong Z; Quan L; Yao S; Zirpoli G; Bandera EV; Roberts M; Coignet JG; Cabasag C; Sucheston L; Hwang H; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Ambrosone CB; Hong CC
PLoS One; 2013; 8(8):e72619. PubMed ID: 23991131
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of racial differences in triple negative breast cancer.
Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
[TBL] [Abstract][Full Text] [Related]
19. Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
Lindner R; Sullivan C; Offor O; Lezon-Geyda K; Halligan K; Fischbach N; Shah M; Bossuyt V; Schulz V; Tuck DP; Harris LN
PLoS One; 2013; 8(11):e71915. PubMed ID: 24260093
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
